Advertisement National Autism Association backs inquiry into vaccine/autism link - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

National Autism Association backs inquiry into vaccine/autism link

The National Autism Association has expressed support for a US Congressional request that the National Institute of Environmental Health Sciences conduct research into the connection between vaccines containing mercury and neurological disorders.

In a letter to National Institute of Environmental Health Sciences (NIEHS) director Dr David Schwartz, eight Congressional and Senate leaders stated that any relevant studies conducted by the Centers for Disease Control and Prevention (CDC) could be viewed with “much skepticism.”

The letter to NIEHS was released to the public following a study by Dr Mark Geier, and David Geier recently published in Journal of American Physicians and Surgeons. The study indicated that reduced exposure to mercury through pediatric vaccines in recent years corresponds with decreased rates of neurodevelopmental disorders, including autism.

In February, the CDC recommended flu shots for children two through five years of age. In 2004, as most pediatric shots became available without thimerosal (mercury), the CDC recommended the influenza vaccine for pregnant women and infants aged six through 23 months.

The National Autism Association (NAA) is concerned about these developments as most flu vaccines contain 12.5 to 25 micrograms of mercury, considered safe by the Environmental Protection Agency for adults weighing between 275 and 550 pounds.

“The CDC has ensured an annual bolus dose of mercury for children from womb to kindergarten,” said NAA board chair Claire Bothwell. “Deliberately increasing exposure to a known neurotoxin calls this agency’s motives into question. The NIEHS is a much preferable choice for conducting the relevant studies.”